Coronavirus Update: J&J’s Single Shot Could Catch Up With Frontrunners

Phase III Trials Launched

 
• By Scrip Team
  
Janssen_Johnson_Johnson
The COVID-19 vaccine project is being led by the Janssen research center in Leiden, the Netherlands.
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from COVID-19

More from Scrip